ATE289348T1

Methods for enhancing the production of viral vaccines in cell culture by interferon suppression

Abstract

Methods for enhancing the production of viral vaccines in animal cell culture are described. These methods rely on the manipulation of the cellular levels of certain interferon induced antiviral activities, in particular, cellular levels of double-stranded RNA (dsRNA) dependent kinase (PKR) and 2'-5' oligoadenylate synthetase (2-5A synthetase). In cell cultures deficient for PKR or 2-5A synthetase, viral yield is enhanced by several orders of magnitude over cell cultures with normal levels of these proteins making these cell cultures useful for the production of viral vaccines.

Term

Term ended

Projected expiry passed 22 August 2016, 10.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

38 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
262195United States of AmericaP
9613745United States of AmericaW

Members38

Family members, oldest first
DocumentOfficeKind
CA2229163A1CanadaA1
CA2229405A1CanadaA1
WO9708292A1World Intellectual Property Organization (WIPO)A1
WO9708324A1World Intellectual Property Organization (WIPO)A1
AU6857696AAustraliaA
AU6860896AAustraliaA
MX9801423AMexicoA
EP0846160A1European Patent Office (EPO)A1
EP0846174A1European Patent Office (EPO)A1
US5840565AUnited States of AmericaA
CN1200148AChinaA
AU707130B2AustraliaB2
BR9610550ABrazilA
JPH11511324AJapanA
JPH11514344AJapanA
US6159712AUnited States of AmericaA
US2001001290A1United States of AmericaA1
US2001001709A1United States of AmericaA1
US2001055791A1United States of AmericaA1
EP0846160A4European Patent Office (EPO)A4
US6489144B1United States of AmericaB1
EP0846174A4European Patent Office (EPO)A4
JP3432519B2JapanB2
US6673591B2United States of AmericaB2
US6686190B2United States of AmericaB2
CA2229405CCanadaC
CN1161469CChinaC
US2004157310A1United States of AmericaA1
US2004219642A1United States of AmericaA1
US6855519B2United States of AmericaB2
EP0846160B1European Patent Office (EPO)B1
AT289348TAustriaT
ATE289348T1This recordAustriaT1
DE69634360D1GermanyD1
DE69634360T2GermanyT2
US7132271B2United States of AmericaB2
JP4267693B2JapanB2
CA2229163CCanadaC